Paul Hsieh, MD of Freedom and Individual Rights in Medicine writes:
The Food and Drug Administration (FDA) is on the verge of taking the highly unusual step of “decertifying” the cancer drug Avastin that it had previously approved. In addition to sparking concerns that this is another step towards medical rationing, ...
From Paul Hsieh:
Recent advances in biotechnology have allowed private companies to offer affordable genetic testing directly to consumers, to help them determine their risks of developing problems such as diabetes, heart disease, and various forms of cancer. In response, the U.S. government has told these companies ...
So says a press release from the Independent Institute:
Oakland, CA, Feb. 10, 2010—The Food and Drug Administration (FDA) has requested a $4.03 billion budget for FY2011, a 23 percent increase over last year. Prompted by the FDA’s vast reach and alarming budget, a new report delves into the organization’s history, ...
David R. Henderson and Charles L. Hooper have an excellent column in Forbes. An excerpt:
Do you need a government agency to tell you which TV has a vivid picture? Do you need a government agency to tell you which car is reliable? How about which coffee tastes yummy or which ...
Charles L. Hooper and David R. Henderson in Forbes:
Since Barack Obama was elected, there has been much hopeful talk about addressing this country's health care problems. Unfortunately, some of the ideas discussed have been bad ones and, therefore, will have predictably bad consequences.
Consider the FDA's recent appointment of Dr. Sidney ...
Daniel Klein, economist at George Mason University, offers his answer to the Davos Question, saying that drugs approved in Canada, Britain, and other places gain automatic approval in the United States. The drug-approving agencies of recognized countries would become more responsive to the needs of humanity. The proposal is called ...
He would, suggests Charles Hooper at Forbes.com. Some selections:
Say a biotech company is developing a new drug for breast cancer. My consulting firm, Objective Insights, looks at the financial value of the project. If the expected value--probability-adjusted value--of the project is negative, we suggest discontinuing development. Often, millions of dollars ...
Fox News, July 23:
The Seattle Mariners are declaring two sections of Safeco Field no-peanut zones for a couple of games this summer.
The AL club announced the move Wednesday to make the ballpark safer for children and grown-up fans with peanut allergies.
This could be a good business decision, but let's hope ...
